Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Robin Foà, MD, from the University of Rome, Rome, Italy, talks about the clinical approach when treating patients with Ph+ or Ph-like acute lymphoblastic leukemia (ALL).